November 15, 2024

Jorge Rubio Gracia: “We face a high level of competition to obtain human and economic resources”

In this interview, the IIS Aragón researcher talks about his work leading the 'Heart Failure Research Group' (GIIS043) and what his most notable project is.
November 14, 2024

New therapeutic approach for severe COVID-19: faster recovery and reduced mortality

An international study, with the participation of the University of Zaragoza and the Aragón Health Research Institute (IIS Aragón), has tested a new therapeutic strategy to treat severe COVID. It is a clinical trial whose results are published in eClinicalMedicine and which could also be applied to other respiratory viruses.
November 13, 2024

ASEICA organizes a “Week of Science in Cancer” with an international congress that will bring together 400 experts

The activities of the “Science Week” in Zaragoza will run from 12 to 16 November 2024. In addition to various informative days and meetings between patients and researchers, several grants will be awarded for cancer research worth a total of 345.000 euros.
November 11, 2024

A new drug promises to curb multiple sclerosis, Parkinson's and Alzheimer's

Researchers at University College London and Loyola University have developed a modified compound of cyclosporin A that blocks cyclophilin D in the brain, offering a new avenue for treating neurodegenerative diseases. Early animal studies show promising results.
November 8, 2024

The IIS Aragón participates in the REGIC Annual Conference

This year, the conference, organised by the Network of Clinical Research Management Entities (REGIC), is being held in Barcelona and the IIS Aragón is once again taking part in this important event.